A persistent problem

被引：0

作者：

Barlow, David H. ^{[1
]}

机构：

[1] Univ Glasgow, Glasgow, Lanark, Scotland

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2012年 / 19卷 / 01期

关键词：

POSTMENOPAUSAL WOMEN; WEEKLY ALENDRONATE; BISPHOSPHONATES; OSTEOPOROSIS; UK;

D O I：

10.1097/gme.0b013e31823cf08e

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：8 / 9

页数：2

共 15 条

[1] The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases [J].

Brankin, Eamonn ;

Walker, Mel ;

Lynch, Niall ;

Aspray, Terence ;

Lis, Yvonne ;

Cowell, Warren .

CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (07) :1249-1256

[2] Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK [J].

Compston, J. ;

Cooper, A. ;

Cooper, C. ;

Francis, R. ;

Kanis, J. A. ;

Marsh, D. ;

McCloskey, E. V. ;

Reid, D. M. ;

Selby, P. ;

Wilkins, M. .

MATURITAS, 2009, 62 (02) :105-108

[3] Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study [J].

Cooper, A. ;

Drake, J. ;

Brankin, E. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) :896-905

[4] A systematic review of persistence and compliance with bisphosphonates for osteoporosis [J].

Cramer, J. A. ;

Gold, D. T. ;

Silverman, S. L. ;

Lewiecki, E. M. .

OSTEOPOROSIS INTERNATIONAL, 2007, 18 (08) :1023-1031

[5]

Cramer JA, 2007, J CLIN DENSITOM, V10, pS219

[6] Long-term persistence with anti hypertensive drugs in new patients [J].

Esposti, ED ;

Sturani, A ;

Di Martino, M ;

Falasca, P ;

Novi, MV ;

Baio, G ;

Buda, S ;

Volpe, M .

JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (06) :439-444

[7] Fracture outcomes related to persistence and compliance with oral bisphosphonates [J].

Gallagher, Arlene M. ;

Rietbrock, Stephan ;

Olson, Melvin ;

van Staa, Tjeerd P. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (10) :1569-1575

[8] ASH Position Paper: Adherence and Persistence With Taking Medication to Control High Blood Pressure [J].

Hill, Martha N. ;

Miller, Nancy H. ;

DeGeest, Sabina .

JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (10) :757-764

[9] Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis [J].

Imaz, I. ;

Zegarra, P. ;

Gonzalez-Enriquez, J. ;

Rubio, B. ;

Alcazar, R. ;

Amate, J. M. .

OSTEOPOROSIS INTERNATIONAL, 2010, 21 (11) :1943-1951

[10]

International Osteoporosis Foundation, STAYING POW CLOS ADH

← 1 2 →